Provided by Tiger Trade Technology Pte. Ltd.

Cocrystal Pharma, Inc.

1.15
-0.0200-1.71%
Post-market: 1.13-0.0200-1.74%19:36 EDT
Volume:84.75K
Turnover:98.19K
Market Cap:22.15M
PE:-1.51
High:1.21
Open:1.19
Low:1.10
Close:1.17
52wk High:2.67
52wk Low:0.7600
Shares:19.26M
Float Shares:11.85M
Volume Ratio:1.14
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7613
EPS(LYR):-0.7822
ROE:-311.68%
ROA:-96.07%
PB:21.22
PE(LYR):-1.47

Loading ...

Company Profile

Company Name:
Cocrystal Pharma, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
10
Office Location:
19805 North Creek Parkway,Bothell,Washington,United States
Zip Code:
98011
Fax:
- -
Introduction:
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.

Directors

Name
Position
Roger Kornberg
Chairman and Director
Fred Hassan
Director
Phillip Frost
Director
Richard C. Pfenniger, Jr.
Director
Steven D. Rubin
Director

Shareholders

Name
Position
James Martin
Co-Chief Executive Officer, Chief Financial Officer
Sam Lee
Co-Chief Executive Officer, President